Medscape

New Risk Model Accurately Predicts Low-Risk Surgery After TAVR

Study validates a new risk model that allows for more accurate risk estimates, encourages shared decision-making, and helps ...
News Medical

TAVR demonstrates lower risk and improved outcomes compared to SAVR in low-risk patients

Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated with substantial decreased rates of death or stroke at one year in low-risk patients, compared ...
Medscape

TAVR Use Expands in Younger Patients, Outpacing Data on Device Durability, Repeat Procedures

Once reserved for very high-risk patients, the use of transcatheter aortic valve replacement in low-risk cases has increased ...

How TAVR Is Changing Heart Care for High‑Risk Patients

TAVR is a less invasive procedure than traditional open-heart surgery, offering faster recovery, reduced risk, and shorter ...
Healio

TAVR noninferior to surgery in real-world lower-risk patient population

Please provide your email address to receive an email when new articles are posted on . Transcatheter aortic valve replacement was noninferior to surgery for death and stroke at 1 year in a real-world ...
Healio

TAVR remains noninferior to surgery for low-risk patients at 5 years

Please provide your email address to receive an email when new articles are posted on . At 5 years, there was no difference in death or disabling stroke between transcatheter aortic valve replacement ...
News Medical

Study evaluates long-term outcomes of TAVR with SAPIEN 3 in intermediate-risk patients

Intermediate-risk patients who received transcatheter aortic valve replacement, known as TAVR, with the latest-generation valve fared better than patients receiving traditional surgical aortic valve ...
The American Journal of Managed Care

ViV-TAVR Leads to Fewer Complications, but Increases Later Heart Failure Hospitalizations and Mortality

From 2015 to 2020, the number of patients opting for valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) over redo surgical aortic valve replacement (SAVR) rose significantly, from 35.3% ...
Tyler Morning Telegraph

Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients

GALWAY, Ireland and CHICAGO, March 30, 2025 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut ...
MedPage Today

First 7-Year Report of Low-Risk TAVR Reassures, With Finish Line Now in Sight

SAN FRANCISCO -- Long-term outcomes after transcatheter aortic valve replacement (TAVR) were looking more and more like those after surgical aortic valve replacement (SAVR) in low-risk patients, ...
Kaleido Scope

Still and Cardiothoracic Surgery faculty publish findings on outcomes for high-risk patients following TAVR explantations

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...